<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Extensive <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation during extracorporeal circulation despite the administration of <z:chebi fb="5" ids="28304">heparin</z:chebi> <z:chebi fb="199" ids="26708">sodium</z:chebi> prompted investigation of a 15-year-old boy with a calcified <z:e sem="disease" ids="C0587043" disease_type="Disease or Syndrome" abbrv="">right ventricular thrombus</z:e> and a history of <z:hpo ids='HP_0011011'>subacute</z:hpo> <z:hpo ids='HP_0006689'>bacterial endocarditis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In vitro studies confirmed the failure of <z:chebi fb="5" ids="28304">heparin</z:chebi> in standard doses to have an <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> effect </plain></SENT>
<SENT sid="2" pm="."><plain>Antithrombin III concentrations were low </plain></SENT>
<SENT sid="3" pm="."><plain>The patient's mother, who had no history of <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo>, was also antithrombin III deficient </plain></SENT>
<SENT sid="4" pm="."><plain>Resistance to <z:chebi fb="5" ids="28304">heparin</z:chebi> is a theoretical, but inconsistently documented, feature of <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>This deficiency state should be considered whenever <z:chebi fb="5" ids="28304">heparin</z:chebi> resistance is encountered, even in the absence of a personal and family history of thromboses </plain></SENT>
</text></document>